Quantifying estrogen metabolism: An evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestrone in urine

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 607-614

  Ziegler, Regina G ^a   Rossi, Susan C ^a   Fears, Thomas R ^a   Bradlow, H Leon ^b   Adlercreutz, Herman ^c   Sepkovic, Daniel ^b   Kiuru, Paula ^c   Wahala, Kristiina ^c   Vaught, Jimmie B ^d   Donaldson, Jennifer L ^a   Falk, Roni T ^a   Fillmore, Capri Mara ^a   Siiteri, Pentti K ^a   Hoover, Robert N ^a   Gail, Mitchell H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Microbiological Associates Inc   (United States)

Author keywords

Breast cancer; Estrogen; Estrogen metabolites; Reproducibility; Validity

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; BIOLOGICAL MARKER; ESTROGEN;

ADULT; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ESTROGEN METABOLISM; FEMALE; FOLLICULAR PHASE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MASS SPECTROMETRY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; URINALYSIS;

EID: 0030925234     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3607     Document Type: Conference Paper

References (28)

1. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65 (1993).
2. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79:3047-3051 (1982).
3. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
4. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R. Effects of pesticides on the ratio of 16α/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Health Perspect 103:147-150 (1995).
5. Longcope C, Gorbach S, Goldin B, Woods M, Dwyer J, Morrill A, Warren J. The effect of a low fat diet on estrogen metabolism. J Clin Endocrinol Metab 64:1246-1250 (1987).
6. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82:947-949 (1990).
7. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GY, Osborne MP. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 3:591-595 (1994).
8. Bradlow HL, Hershcopf RJ, Marrucci CP, Fishman J. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 82:6295-6299 (1985).
9. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Estrogen metabolite 16α-hydroxyestrone induces genotoxic damage and aberrant cell proliferation in mouse mammary epithelial cells in culture. J Natl Cancer Inst 84:634-638 (1992).
10. Osborn MP, Bradlow HL, Wong GYC, Telang NT. Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J Natl Cancer Inst 85:1917-1920 (1993).
11. Adlercreutz H, Fotsis T, Bannwart C, Wahala K, Makela T, Brunow G, Hase T. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Steroid Biochem 24:289-296 (1986).
12. Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S, Valtonen A, Ollus A. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 34:527-530 (1989).
13. Adlercreutz H. Diet and sex hormone metabolism. In: Nutrition, Toxicity, and Cancer (Rowland IR, ed). Boca Raton, FL:CRC Press, 1991;137-195.
14. Klug TL, Bradlow HL, Sepkovic DW. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine. Steroids 59:648-655 (1994).
15. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819-1827 (1993).
16. Fotsis T, Adlercreutz H. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS. 1: Quantitation of estrogens after initial hydrolysis of conjugates. J Steroid Biochem 28:203-213 (1987).
17. Bannwart C, Adlercreutz H, Wahala K, Brunow G, Hase T. Deuterium labelled ethoximes as stable isotope internal standards in the GC-MS-SIM determination of oxo-estrogens in human urine extracts: preliminary results. In: Proceedings of the Symposium on the Analysis of Steroids, 20-22 October 1987, Sopron, Hungary (Gorog S, Heftmann E, eds). Advances in Steroid Analysis, 1987. Budapest, Hungary:Akademiai Kiado, 1988:283-286.
18. Gail MH, Fears TR, Hoover RN, Chandler DW, Donaldson JL, Hyer MB, Pee D, Ricker WV, Siiteri PK, Stanczyk FZ, et al. Reproducibility studies and between-laboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate and progesterone. Cancer Epidemiol Biomarkers Prev 5:835-844 (1996).
19. Lemon HM, Wotiz HH, Parsons L, Mazden PJ. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. JAMA 196:1128-1136 (1966).
20. Lemon HM. Endocrine influences on human mammary cancer formation. A critique. Cancer 23:781-790 (1969).
21. MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst 50:21-42 (1973).
22. Cole P, Cramer D, Yen S, Paffenbarger R, MacMahon B, Brown J. Estrogen profiles of premenopausal women with breast cancer. Cancer Res 38:745-748 (1978).
23. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86:1076-1082 (1994).
24. Bradlow HL. Personal communication.
25. Cauley JA, Gutai JP, Kuller LH, Powell JG. Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 133:50-57 (1991).
26. Hankinson SE, Manson JE, London SJ, Willett WC, Speizer FE. Laboratory reproducibility of endogenous hormone levels in postmenopausal women. Cancer Epidemiol Biomarkers Prev 3:51-56 (1994).
27. Potischman N, Falk RT, Laiming VA, Siiteri PK, Hoover RN. Reproducibility of laboratory assays for steroid hormones and sex hormone-binding globulin. Cancer Res 54:5363-5367 (1994).
28. Toniolo P, Koenig KL, Pasternack BS, Banerjee S, Rosenberg C, Shore RE, Strax P, Levitz M. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 3:47-50 (1994).